<DOC>
	<DOCNO>NCT01756365</DOCNO>
	<brief_summary>The study `` Autologous culture corneal epithelium ( CECA ) treatment unilateral corneal lesion associate limbal stem cell deficiency '' first clinical trial product manufacture LOEX laboratory . The culture corneal epithelium strive produce reconstruct tissue therapeutical aim treatment unilateral limbal stem cell deficiency ( one eye affect limbal stem cell deficiency ) . The study phase I/phase II study goal evaluate safety efficacy CECA graft treatment human patient suffer limbal stem cell deficiency .</brief_summary>
	<brief_title>Autologous Cultured Corneal Epithelium ( CECA ) Treatment Limbal Stem Cell Deficiency</brief_title>
	<detailed_description />
	<criteria>Male female patient limbal stem cell deficiency Bilateral limbal stem cell deficiency Unilateral limbal stem cell deficiency 50 % damage contralateral eye Pregnancy Breastfeeding Minors known allergy aprotinine ( Trasylol ( R ) ) Hypersensibility bovine protein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>